Update on the appropriate use of linezolid in clinical practice
about
Update on the safety of linezolid.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formation by a human wound-associated strain.Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria.
P2860
Update on the appropriate use of linezolid in clinical practice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on the appropriate use of linezolid in clinical practice
@en
Update on the appropriate use of linezolid in clinical practice.
@nl
type
label
Update on the appropriate use of linezolid in clinical practice
@en
Update on the appropriate use of linezolid in clinical practice.
@nl
prefLabel
Update on the appropriate use of linezolid in clinical practice
@en
Update on the appropriate use of linezolid in clinical practice.
@nl
P2860
P1476
Update on the appropriate use of linezolid in clinical practice
@en
P2093
Roberto Manfredi
P2860
P304
P356
10.2147/TCRM.2006.2.4.455
P577
2006-12-01T00:00:00Z